Oral and infusion levodopa-based strategies for managing motor complications in patients with Parkinson's disease.
about
Levodopa-carbidopa intestinal gel in advanced Parkinson's disease: final 12-month, open-label resultsMotor and nonmotor complications in Parkinson's disease: an argument for continuous drug delivery?Levodopa-carbidopa enteral suspension in advanced Parkinson's disease: clinical evidence and experience.Continuous intestinal infusion of levodopa/carbidopa in advanced Parkinson's disease: efficacy, safety and patient selection.Novel levodopa formulations in the treatment of Parkinson's disease.Novel formulations and modes of delivery of levodopa.Best practice in placement of percutaneous endoscopic gastrostomy with jejunal extension tube for continuous infusion of levodopa carbidopa intestinal gel in the treatment of selected patients with Parkinson's disease in the Nordic region.Advanced stages of PD: interventional therapies and related patient-centered care.New treatments for levodopa-induced motor complications.Is there room for new non-dopaminergic treatments in Parkinson's disease?Long-term effectiveness of levodopa-carbidopa intestinal gel in 177 Spanish patients with advanced Parkinson's disease.Effect of Levodopa-carbidopa Intestinal Gel on Non-motor Symptoms in Patients with Advanced Parkinson's Disease.Systematic evaluation of levodopa-carbidopa intestinal gel patient-responder characteristics.Treatment of advanced Parkinson's disease.
P2860
Q36361513-54349C86-BFCC-4326-BD61-39CD1CFFF435Q37115650-38D5C84E-1BB1-4C80-9BBC-4A26140AD98BQ37698585-9442BD75-59EB-4967-9F39-C52CCFC7069FQ38080952-D227C417-E670-4DBD-AABA-4ABBA40707A8Q38178754-9E873B8D-84C4-4AF8-B84C-C326D9300480Q38283415-1E16EAAB-94B0-41DE-A1CB-1902EE939C2DQ38530328-3188808E-DDF2-4B39-BCAF-B99C90CAFD13Q38542180-CA52D9B7-E0C5-4F21-B512-0F54F0956B07Q38570434-B8A245C4-BA10-4582-A19F-5D480A17D231Q39505368-B486F872-651F-44D7-BC9C-802491D54431Q39578837-25236F88-DE96-46BA-BD5B-D257E856481CQ47120831-18FEBACF-CC7B-4BDB-9087-81B64050386DQ48128791-91F69A7F-3BBC-44F2-9955-0C02CED7633EQ55645561-8118369A-6E45-44C5-BECE-A87F952F3A31
P2860
Oral and infusion levodopa-based strategies for managing motor complications in patients with Parkinson's disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Oral and infusion levodopa-bas ...... ents with Parkinson's disease.
@en
Oral and infusion levodopa-bas ...... ents with Parkinson's disease.
@nl
type
label
Oral and infusion levodopa-bas ...... ents with Parkinson's disease.
@en
Oral and infusion levodopa-bas ...... ents with Parkinson's disease.
@nl
prefLabel
Oral and infusion levodopa-bas ...... ents with Parkinson's disease.
@en
Oral and infusion levodopa-bas ...... ents with Parkinson's disease.
@nl
P2860
P50
P1433
P1476
Oral and infusion levodopa-bas ...... ents with Parkinson's disease.
@en
P2860
P304
P356
10.2165/11310940-000000000-00000
P577
2010-02-01T00:00:00Z
P6179
1026490508